{
  "abstract": "Background: A large and increasing number of people are forcibly displaced worldwide because of war, food insecurity, and other crises. Streptococcus pneumoniae likely causes a substantial health burden in crisis-affected populations. Pneumococcal conjugate vaccines (PCVs) are widely used in routine immunisation programmes, including through the Essential Programme on Immunization (EPI) to protect against pneumococcal disease. They are typically administered as a three-dose schedule, either as three doses in early infancy or two doses in infancy followed by a booster at 9–18 months of age. However, PCVs are rarely used in humanitarian responses. We evaluated the potential impact of logistically feasible PCV campaigns in such settings. Methods and findings: We conducted a pneumococcal carriage, malnutrition, and social contact survey in a camp for displaced people near Hargeisa, Somaliland, to parameterise a transmission model accounting for migration. We projected the effect of PCV mass-vaccination campaigns using one or two doses and vaccinating children <1, 2, 5, 10, or 15 years (y) of age in the Somaliland camp and three different crisis settings. We found that a single-dose PCV campaign with high vaccine coverage in children <5 y or older can partially control vaccine-serotypes for up to 3 y, preventing 27% (95% CrI: 20, 34) of severe pneumococcal disease, defined as a composite of invasive pneumococcal disease and nonbacteraemic pneumonia, when vaccinating <5 y olds and 38% (95% CrI: 29, 46) when vaccinating <15 y olds. Expanded age eligibility is needed for comparable protection in settings with increased migration or more interaction with unvaccinated host populations. A campaign vaccinating <5 y olds is the most efficient use of PCV with 108 (95% CrI 77–162) vaccines needed to prevent one case of severe pneumococcal disease. Implementing such campaigns in displaced populations worldwide would require about 30 million doses in the next 5 y. Key limitations included sparse empirical data on PCV effectiveness and pneumococcal disease in humanitarian settings, and extrapolation of Somaliland carriage and contact patterns to other crisis settings. Conclusions: Single-dose mass-vaccination campaigns offer crisis-affected populations an effective, pragmatic immunisation strategy to deliver PCVs if routine EPI services have been disrupted. Why was this study done?: What did the researchers do and find?: What do these findings mean?: In a modelling study, Kevin van Zandvoort and colleagues find that a single dose of pneumococcal vaccine in children less than 5 yrs could protect against severe disease in humanitarian settings where routine immunization is disrupted.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom",
    "Health and Nutrition, Save the Children International, Hargeisa, Somaliland",
    "Republic of Somaliland Ministry of Health Development, Hargeisa, Somaliland",
    "Save the Children, London, United Kingdom",
    "Infection, Immunity and Global Health, Murdoch Children’s Research Institute, The University of Melbourne Department of Paediatrics at the Royal Children’s Hospital, Melbourne, Australia",
    "Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia",
    "Centre for Global Health, Charité - Universitätsmedizin Berlin, Berlin, Germany"
  ],
  "article_type": "Research Article",
  "arxiv": null,
  "author_total": 15,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Kevin van Zandvoort"
    },
    {
      "affs": [
        1
      ],
      "name": "Mohamed O. Bobe"
    },
    {
      "affs": [
        2
      ],
      "name": "Abdirahman I. Hassan"
    },
    {
      "affs": [
        3
      ],
      "name": "Rachael Cummings"
    },
    {
      "affs": [
        4
      ],
      "name": "Abdihamid Warsame"
    },
    {
      "affs": [
        5
      ],
      "name": "Casey L. Pell"
    },
    {
      "affs": [
        6
      ],
      "name": "Mohamed Ismail Abdi"
    },
    {
      "name": "Saed Ibrahim"
    },
    {
      "name": "Catherine R. McGowan"
    },
    {
      "name": "E. Kim Mulholland"
    },
    {
      "name": "Catherine Satzke"
    },
    {
      "name": "Rosalind M. Eggo"
    },
    {
      "name": "Mohamed Abdi Hergeye"
    },
    {
      "name": "Francesco Checchi"
    },
    {
      "name": "Stefan Flasche"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ejhqvgekw043x.bib",
  "cited_by": 0,
  "doi": "10.1371/journal.pmed.1004768",
  "fulltext_url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004768",
  "id": "ejhqvgekw043x",
  "issns": [
    "1549-1676"
  ],
  "landing_url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004768",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "plos",
      "/Biology and life sciences/Immunology/Vaccination and immunization"
    ],
    [
      "plos",
      "/Medicine and health sciences/Epidemiology/Infectious disease epidemiology"
    ],
    [
      "plos",
      "/Medicine and health sciences/Epidemiology/Medical risk factors"
    ],
    [
      "plos",
      "/Medicine and health sciences/Immunology/Vaccination and immunization"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Infectious diseases/Infectious disease control/Vaccines"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Infectious diseases/Infectious disease control/Vaccines/Conjugate vaccines"
    ],
    [
      "plos",
      "/Medicine and health sciences/Medical conditions/Infectious diseases/Infectious disease epidemiology"
    ],
    [
      "plos",
      "/Medicine and health sciences/Public and occupational health/Preventive medicine/Vaccination and immunization"
    ],
    [
      "plos",
      "/People and places/Population groupings/Age groups"
    ],
    [
      "plos",
      "/People and places/Population groupings/Age groups/Children"
    ],
    [
      "plos",
      "/People and places/Population groupings/Age groups/Children/Infants"
    ],
    [
      "plos",
      "/People and places/Population groupings/Families/Children"
    ],
    [
      "plos",
      "/People and places/Population groupings/Families/Children/Infants"
    ]
  ],
  "openalex": null,
  "pdf_url": "https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004768&type=printable",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-11",
  "publisher": "Public Library of Science",
  "ris": "https://research.draconitic.com/paper/ejhqvgekw043x.ris",
  "sources": [
    {
      "first_seen": "2026-11-12T12:20:55Z",
      "native_id": "10.1371/journal.pmed.1004768",
      "source": "plos",
      "url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004768"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "plos:immunology",
      "subfield": "immunology"
    },
    {
      "field": "medicine",
      "origin": "plos:epidemiology",
      "subfield": "epidemiology-public-health"
    },
    {
      "field": "medicine",
      "origin": "plos:infectious diseases",
      "subfield": "infectious-disease"
    }
  ],
  "title": "Effectiveness of pneumococcal vaccination campaigns in humanitarian settings: A modelling study",
  "title_text": "Effectiveness of pneumococcal vaccination campaigns in humanitarian settings: A modelling study",
  "type": "peer-reviewed",
  "updated_at": "2026-11-13T12:20:02Z",
  "url": "https://research.draconitic.com/paper/ejhqvgekw043x",
  "venue": "PLOS Medicine",
  "versions": []
}